| A TP53-associated immune prognostic signature for the prediction of overall survival and therapeutic responses in muscle-invasive bladder cancer X Wu, D Lv, C Cai, Z Zhao, M Wang, W Chen, Y Liu Frontiers in immunology 11, 590618, 2020 | 53 | 2020 |
| Day-surgery percutaneous nephrolithotomy: a high-volume center retrospective experience X Wu, Z Zhao, H Sun, C Cai, Z Li, D Cheng, H Zhu, G Zeng, Y Liu World journal of urology 38, 1323-1328, 2020 | 30 | 2020 |
| A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy D Lv, X Wu, X Chen, S Yang, W Chen, M Wang, Y Liu, D Gu, G Zeng Cancer Immunology, Immunotherapy 70 (12), 3587-3602, 2021 | 24 | 2021 |
| Multiple-tract percutaneous nephrolithotomy as a day surgery for the treatment of complex renal stones: an initial experience H Zhu, Z Zhao, D Cheng, X Wu, G Yue, Y Lei, Z Li, G Zeng, Y Liu World Journal of Urology 39, 921-927, 2021 | 23 | 2021 |
| Evaluation of day-care versus inpatient mini-percutaneous nephrolithotomy: a propensity score-matching study Z Zhao, H Sun, X Wu, C Cai, Y Liu, G Zeng Urolithiasis 48, 209-215, 2020 | 20 | 2020 |
| A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score≥ 7 X Wu, D Lv, M Lei, C Cai, Z Zhao, M Eftekhar, D Gu, Y Liu Oncology letters 20 (3), 2906-2918, 2020 | 18 | 2020 |
| CD8+ T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma X Wu, D Jiang, H Liu, X Lu, D Lv, L Liang Frontiers in Immunology 12, 745945, 2021 | 16 | 2021 |
| Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis X Wu, H Yan, M Qiu, X Qu, J Wang, S Xu, Y Zheng, M Ge, L Yan, L Liang Elife 12, e86032, 2023 | 15 | 2023 |
| Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer Y Zhang, Y Lin, D Lv, X Wu, W Li, X Wang, D Jiang PeerJ 10, e12843, 2022 | 15 | 2022 |
| Comparison of the prone split-leg position with the traditional prone position in percutaneous nephrolithotomy: A propensity score-matching study G Yue, Y Lei, MA Karagöz, H Zhu, D Cheng, C Cai, X Wu, Z Li, Y Zhao, ... Journal of endourology 35 (9), 1333-1339, 2021 | 14 | 2021 |
| Claspin Overexpression Promotes Tumor Progression and Predicts Poor Clinical Outcome in Prostate Cancer C Cai, J Luo, Q Liu, Z Liu, Y Zhao, X Wu, Y Yuegao, Y Lei, J Lu, Y Wang, ... Genetic Testing and Molecular Biomarkers 25 (2), 131-139, 2021 | 11 | 2021 |
| A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients X Wu, D Lv, M Eftekhar, A Khan, C Cai, Z Zhao, D Gu, Y Liu Translational Andrology and Urology 9 (6), 2572, 2020 | 11 | 2020 |
| Functional assessment of four novel immune-related biomarkers in the pathogenesis of clear cell renal cell carcinoma D Lv, X Wu, M Wang, W Chen, S Yang, Y Liu, G Zeng, D Gu Frontiers in Cell and Developmental Biology 9, 621618, 2021 | 10 | 2021 |
| The impact of nephrostomy drainage prior to mini-percutaneous nephrolithotomy in patients with ESBL-positive Escherichia coli Z Zhao, W Wu, T Zeng, X Wu, Y Liu, G Zeng World journal of urology 39, 239-246, 2021 | 8 | 2021 |
| Identification of a novel signature and construction of a nomogram predicting overall survival in clear cell renal cell carcinoma X Wu, Z Zhao, A Khan, C Cai, D Lv, D Gu, Y Liu Frontiers in Genetics 11, 1017, 2020 | 7 | 2020 |
| Cause-specific mortality of low and selective intermediate-risk prostate cancer patients with active surveillance or watchful waiting X Wu, D Lv, M Eftekhar, C Cai, Z Zhao, D Gu, Y Liu Translational Andrology and Urology 10 (1), 154, 2021 | 5 | 2021 |
| Identification and validation of a prognostic 5-protein signature for biochemical recurrence following radical prostatectomy for prostate cancer D Lv, Z Cao, W Li, H Zheng, X Wu, Y Liu, D Gu, G Zeng Frontiers in Surgery 8, 665115, 2021 | 1 | 2021 |